Helius Medical Technologies (HSDT) News Today $0.18 -0.03 (-13.74%) As of 06/30/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock HSDT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Helius Medical Technologies Announces 1-for-50 Reverse Stock Split Effective June 30, 2025 - NasdaqJune 29 at 11:19 AM | nasdaq.comHelius Medical Technologies Announces Reverse Stock SplitJune 27, 2025 | globenewswire.comHSDT Helius Medical Technologies, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comHelius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 16, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 16, 2025 | globenewswire.comHelius Medical Technologies, Inc.: Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual MeetingJune 13, 2025 | finanznachrichten.dePositive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual MeetingJune 12, 2025 | globenewswire.comHelius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 11, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) DeviceJune 11, 2025 | globenewswire.comHelius Medical Technologies stock falls after pricing capital raise of $9.1M via securities offeringJune 5, 2025 | msn.comHelius Medical Technologies Announces Pricing of $9.1 Million Public OfferingJune 4, 2025 | globenewswire.comHelius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing CriteriaJune 4, 2025 | financialpost.comFHelius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing CriteriaJune 4, 2025 | globenewswire.comHelius Medical Technologies to Present Breakthrough PoNS Study Results at CMSC Annual MeetingMay 23, 2025 | msn.comHelius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual MeetingMay 20, 2025 | globenewswire.comHelius Medical Technologies Secures Key Reimbursement Approval for PoNS DeviceMay 17, 2025 | msn.comHelius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) DeviceMay 12, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) DeviceMay 12, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) DeviceMay 12, 2025 | globenewswire.comHelius Announces 1-for-15 Reverse Stock Split To Regain Nasdaq ComplianceMay 2, 2025 | nasdaq.comHelius Medical Technologies initiates 1-for-15 reverse stock split to meet Nasdaq requirementsMay 1, 2025 | bizjournals.comHelius Medical Technologies Announces Reverse Stock SplitApril 30, 2025 | globenewswire.comMaxim Group Remains a Hold on Helius Medical Technologies (HSDT)March 30, 2025 | theglobeandmail.comHelius Medical Unveils Revelation Neuro to Pioneer AI-Powered NeurorehabilitationMarch 14, 2025 | msn.comHelius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private SubsidiaryMarch 13, 2025 | globenewswire.comHelius Medical announces first reimbursement for PoNS DeviceMarch 11, 2025 | markets.businessinsider.comHelius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) DeviceMarch 11, 2025 | globenewswire.comHelius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program StudyJanuary 22, 2025 | globenewswire.comHelius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-MarketJanuary 21, 2025 | investing.comHelius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-MarketJanuary 21, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-MarketJanuary 21, 2025 | financialpost.comFHelius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-MarketJanuary 21, 2025 | globenewswire.comThis Micro Cap Found Tremendous Mid-Week Success On Key AnnouncementJanuary 21, 2025 | msn.comHelius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study Exceeding Initial TargetJanuary 21, 2025 | finance.yahoo.comHelius exceeds stroke study enrollment goalsJanuary 21, 2025 | msn.comHelius Medical Technologies, Inc. Announces Strong Enrollment of its Stroke Pivotal Study ...January 21, 2025 | gurufocus.comHelius Medical announces first PoNS System sale to VA Healthcare SystemDecember 23, 2024 | markets.businessinsider.comHelius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare SystemDecember 23, 2024 | globenewswire.comHelius Medical Technologies Seeks Fair Market Access for PoNS Device Amid CMS Pricing ChallengesNovember 21, 2024 | msn.comHelius Medical Technologies Considers Strategic Alternatives Amid Financial ChallengesNovember 21, 2024 | msn.comHelius Medical Technologies (HSDT) Gets a Hold from Maxim GroupNovember 20, 2024 | markets.businessinsider.comHelius Medical Technologies, Inc. Announces Exploration of Strategic AlternativesNovember 18, 2024 | markets.businessinsider.comHelius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) DeviceNovember 18, 2024 | globenewswire.comHelius Medical Technologies Faces Nasdaq Delisting Risk Due to Stock Price Non-ComplianceNovember 15, 2024 | markets.businessinsider.comHelius Medical Technologies to Shine at ThinkEquity Conference in NYC!October 18, 2024 | msn.comHelius Medical Technologies, Inc. to Present at the 2024 ThinkEquity ConferenceOctober 18, 2024 | globenewswire.comMaxim Group Downgrades Helius Medical Technologies (HSDT)October 17, 2024 | msn.comHelius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and MouthpieceOctober 14, 2024 | globenewswire.comHelius Medical Technologies Reports Positive Preliminary Results from PoNSTEP StudyOctober 1, 2024 | msn.comHelius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP StudySeptember 30, 2024 | financialpost.comF Get Helius Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter. Email Address HSDT Media Mentions By Week HSDT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HSDT News Sentiment▼0.160.90▲Average Medical News Sentiment HSDT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HSDT Articles This Week▼51▲HSDT Articles Average Week Get Helius Medical Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SONX News Today BIOL News Today STSS News Today AFIB News Today BRSH News Today DRTSW News Today HSCSW News Today BEATW News Today LUCYW News Today IINNW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HSDT) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helius Medical Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Helius Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSDT Stock Alerts